Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS

Lalezari JP, Kemper C, Stagg R, Holland G, Ives D, Kramer F, Northfelt D, Kuppermann B, Lewis R, Youle M, Weinberg D, McKinley G, Johnson M, Hardy D, Simon G, Nelson R, Drew WL,Jaffe HS. A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. Int Conf AIDS - Abstract. 1996; 11(2):226.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.